side effects tirzepatide vs semaglutide Weighing up the Risks: GI of Tirzepatide and Semaglutide: Safety, Science,

GLP-1 is the FDA-approved brand name version of GLP-1 specifically approved for weight management

10.1007/s00401-012-1003-7 61 JaromeT

In pancreatic beta cells, GLP-1 receptor activation enhances glucose-dependent insulin secretion

Getting to a higher dose quicker leads to quicker weight loss, but may increase the risk of gastrointestinal side effects initially

If you have anorexia, your doctor will decide if you need amino acid replacement or not

Semaglutide side effects include nausea, vomiting, diarrhea, constipation, abdominal pain, and potential thyroid concerns, with gastrointestinal symptoms being most common initially